Aerie Pharmaceuticals, Inc. EBITDA Margin 2013-2022 | AERI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Aerie Pharmaceuticals, Inc. (AERI) over the last 10 years. The current EBITDA margin for Aerie Pharmaceuticals, Inc. as of September 30, 2022 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-09-30 | $0.21B | $-0.01B | -2.80% |
| 2022-06-30 | $0.21B | $-0.01B | -2.90% |
| 2022-03-31 | $0.20B | $-0.01B | -6.47% |
| 2021-12-31 | $0.19B | $-0.01B | -4.12% |
| 2021-09-30 | $0.10B | $-0.10B | -93.27% |
| 2021-06-30 | $0.10B | $-0.10B | -104.21% |
| 2021-03-31 | $0.09B | $-0.11B | -129.07% |
| 2020-12-31 | $0.08B | $-0.12B | -146.99% |
| 2020-09-30 | $0.08B | $-0.14B | -165.06% |
| 2020-06-30 | $0.08B | $-0.15B | -185.37% |
| 2020-03-31 | $0.08B | $-0.16B | -200.00% |
| 2019-12-31 | $0.07B | $-0.17B | -238.03% |
| 2019-09-30 | $0.06B | $-0.18B | -295.00% |
| 2019-06-30 | $0.05B | $-0.20B | -410.42% |
| 2019-03-31 | $0.03B | $-0.21B | -617.65% |
